CIK 0000860730 · Large accelerated filer
HCA Healthcare, Inc.
Sign in to watch- Ticker
- HCA
- Exchange
- NYSE
- Industry
- Services-General Medical & Surgical Hospitals, NEC
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 273865930
- Phone
- 6153449551
- Business address
- ONE PARK PLZ, NASHVILLE, TN, 37203
- Former names
- HCA Holdings, Inc., HCA INC/TN, HCA THE HEALTHCARE CO, HCA-THE HEALTHCARE CO, COLUMBIA HCA HEALTHCARE CORP, COLUMBIA HCA HEALTHCARE CORP/, COLUMBIA HEALTHCARE CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $18,251,400
- in 3 filings
Net −$18,251,400. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-07-25 | Torres Kathryn A. SVP-Payer Contracting & Align. | Sale | −1,857 | $355.05 | $659K | 17,755 |
| 2024-05-17 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise | +3,040 | $101.16 | $308K | 12,494 |
| 2024-05-17 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise | +1,685 | $133.53 | $225K | 14,179 |
| 2024-05-17 | Whalen Kathleen M SVP & Chief Ethics Officer | Shares withheld for taxes | −2,861 | $322.86 | $924K | 11,318 |
| 2024-05-17 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise · Stock Appreciation Right | −3,040 | 0 | ||
| 2024-05-17 | Whalen Kathleen M SVP & Chief Ethics Officer | Option exercise · Stock Appreciation Right | −1,685 | 12,045 | ||
| 2024-05-16 | Whalen Kathleen M SVP & Chief Ethics Officer | Sale | −3,204 | $326.30 | $1.0M | 9,454 |
| 2024-05-15 | Foster Jon M EVP and COO | Gift | −5,350 | 0 | ||
| 2024-05-15 | Foster Jon M EVP and COO | Gift | +5,350 | 54,308 | ||
| 2024-05-15 | Torres Kathryn A. SVP-Payer Contracting & Align. | Sale | −1,863 | $326.18 | $608K | 19,612 |
| 2024-05-15 | Sowell Joseph A III SVP; Chief Development Officer | Option exercise | +19,000 | $68.96 | $1.3M | 23,275 |
| 2024-05-15 | Sowell Joseph A III SVP; Chief Development Officer | Shares withheld for taxes | −9,908 | $326.96 | $3.2M | 13,367 |
| 2024-05-15 | Sowell Joseph A III SVP; Chief Development Officer | Option exercise · Stock Appreciation Right | −19,000 | 0 | ||
| 2024-05-15 | Foster Jon M EVP and COO | Option exercise | +11,955 | $69.58 | $832K | 33,785 |
| 2024-05-15 | Foster Jon M EVP and COO | Option exercise | +27,510 | $81.96 | $2.3M | 61,295 |
| 2024-05-15 | Foster Jon M EVP and COO | Shares withheld for taxes | −21,258 | $326.96 | $7.0M | 40,037 |
| 2024-05-15 | Foster Jon M EVP and COO | Option exercise · Stock Appreciation Right | −11,955 | 0 | ||
| 2024-05-15 | Foster Jon M EVP and COO | Option exercise · Stock Appreciation Right | −27,510 | 0 | ||
| 2024-05-09 | Cuffe Michael S. EVP and Chief Clinical Officer | Sale | −6,311 | $316.88 | $2.0M | 29,623.97 |
| 2024-05-09 | Cohen Jeffrey E. SVP-Government Relations | Sale | −1,650 | $313.00 | $516K | 5,185 |
Page 13 of 56 · 1,102 trades